Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Development and validation of a multiplex bead based assay for the detection of antibodies directed against SARS-CoV-2 proteins

Robert A. Bray, Jar-How Lee, Peter Brescia, Deepali Kumar, Thoa Nong, Remi Shih, E. Steve Woodle, Jonathan S. Maltzman, View ORCID ProfileHoward M. Gebel
doi: https://doi.org/10.1101/2020.09.02.20185199
Robert A. Bray
1Emory University, Department of Pathology, Division of Laboratory Medicine, Atlanta, GA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jar-How Lee
2Terasaki Innovation Center, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Brescia
3One Lambda Inc., Inc., Division of Thermo Fisher Scientific, West Hills, Ca
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deepali Kumar
4Transplant Infectious Diseases, Multi-Organ Transplant Program, University Health Network, Toronto, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thoa Nong
3One Lambda Inc., Inc., Division of Thermo Fisher Scientific, West Hills, Ca
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Remi Shih
3One Lambda Inc., Inc., Division of Thermo Fisher Scientific, West Hills, Ca
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E. Steve Woodle
5University of Cincinnati, College of Medicine, Department of Surgery, Division of Transplantation, Cincinnati, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan S. Maltzman
6Stanford University School of Medicine, Department of Medicine, Palo Alto, CA and VA Palo Alto Health Care System, Palo Alto, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Howard M. Gebel
1Emory University, Department of Pathology, Division of Laboratory Medicine, Atlanta, GA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Howard M. Gebel
  • For correspondence: hgebel{at}emory.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Transplant recipients who develop COVID-19 may be at increased risk for morbidity and mortality. Determining antibody status against SARS-CoV-2 in candidates and recipients will be important to understand the epidemiology and clinical course of COVID-19 infection in this population. There are multiple antibody tests to detect antibodies to SARS-CoV-2, but their performance varies according to their platforms and the antigenic targets, making interpretation of the results challenging. Additionally, currently available serological tests do not exclude the possibility that positive responses are due to cross reactive antibodies to community coronaviruses. This study describes the development and validation of a high throughput multiplex bead based antibody detection assay with the capacity to identify, simultaneously, patient responses to five distinct SARS-CoV-2 proteins. The antibody response to these proteins are SARS-CoV-2 specific as antibodies against four community coronaviruses do not cross-react. Assay configuration is essentially identical to the single antigen bead assays used in the majority of histocompatibility laboratories around the world and could easily be implemented into routine screening of transplant candidates and recipients. This new assay provides a novel tool to interrogate the spectrum of immune responses to SAR-CoV-2 and is uniquely suitable for use in the transplant setting.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No external funding

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Emory University Institutional Review Board reviewed and considered the data to be in the interest of public health. Ethics approval was waived.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ORCiDs Robert A. Bray, Ph.D.: 0000-0003-3598-5180

  • Jar-How Lee, Ph.D.: 0000-0002-2565-4276

  • Deepali Kumar, M.D.: 0000-0003-1961-0477

  • E.Steve Woodle, M.D.: 100000-0003-4280-0842

  • Jonathan S. Maltzman, M.D., Ph.D.: 0000-0001-5722-269X

  • Howard M. Gebel, Ph.D.: 0000-0003-0197-2752

Data Availability

Data available upon reasonable request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted September 03, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Development and validation of a multiplex bead based assay for the detection of antibodies directed against SARS-CoV-2 proteins
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Development and validation of a multiplex bead based assay for the detection of antibodies directed against SARS-CoV-2 proteins
Robert A. Bray, Jar-How Lee, Peter Brescia, Deepali Kumar, Thoa Nong, Remi Shih, E. Steve Woodle, Jonathan S. Maltzman, Howard M. Gebel
medRxiv 2020.09.02.20185199; doi: https://doi.org/10.1101/2020.09.02.20185199
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Development and validation of a multiplex bead based assay for the detection of antibodies directed against SARS-CoV-2 proteins
Robert A. Bray, Jar-How Lee, Peter Brescia, Deepali Kumar, Thoa Nong, Remi Shih, E. Steve Woodle, Jonathan S. Maltzman, Howard M. Gebel
medRxiv 2020.09.02.20185199; doi: https://doi.org/10.1101/2020.09.02.20185199

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)